Crystallization Resolution of a Racemic Compound (R,S)-Sulpiride Promoted by Chiral Ionic Liquids: Insight into the Effect on Selective Nucleation

This study systematically investigates the influence of chiral ionic liquids (CILs) on the enantiomeric resolution efficiency of chiral drugs via crystallization. Four CILs―1-pentyl-3-methylimidazolium-R-mandelate ([Pmim][R-MA]), 1-pentyl-3-methylimidazolium-R-pyroglutamate ([Pmim][R-PgA]), 1-pentyl-3-methylimidazolium-S-mandelate ([Pmim][S-MA]), and 1-pentyl-3-methylimidazolium-S-pyroglutamate ([Pmim][S-PgA])―previously synthesized and characterized in prior research were employed in a methanol-based system to evaluate their effects on the nucleation kinetics and crystallization resolution of the model drug RS-sulpiride (RS-Sul). Nucleation probability analysis revealed that R-enantiomeric CILs (R-CILs) preferentially facilitated the nucleation of S-sulpiride (S-Sul), exhibiting intermolecular interactions with S-Sul that are significantly stronger than those with R-sulpiride (R-Sul). Furthermore, a CIL-based cosolvent mixture (CCM) with a mass fraction (ω) of 0.7 (CCM-0.7) was identified as a highly effective nucleation inhibitor, selectively suppressing the crystallization of enantiomers with identical chiral configurations while promoting the nucleation of their opposite enantiomers. In a methanol-based system containing 7 wt % R-CILs, variations in solvent composition and seeding concentrations significantly influenced the crystallization resolution efficiency of RS-Sul. The chiral recognition mechanism between CILs and Sul enantiomers was revealed by an independent gradient model based on Hirshfeld partition (IGMH) analysis as well as binding energy (BE) calculations, which further demonstrated that [Pmim][R-PgA] exhibited superior chiral recognition compared to [Pmim][R-MA], elucidating the molecular-level mechanism of CIL-mediated stereoselective nucleation. Additionally, cyclic stability assessments revealed that after six reuse cycles, the CILs retained a 93.8% recovery efficiency and structural integrity, highlighting their potential for practical applications in chiral resolution.

Authors

Institutions

Publication Details

Journal
Crystal Growth & Design
Published
2025-04-24
DOI
https://doi.org/10.1021/acs.cgd.4c01646
Citations
4
Primary Topic
Analytical Chemistry and Chromatography
Type
article
Field-Weighted Citation Impact
3.03

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Crystallization Resolution of a Racemic Compound (R,S)-Sulpiride Promoted by Chiral Ionic Liquids: Insight into the Effect on Selective Nucleation

Liang Shu, Jie Lü, Yinxin Yang, Longlong Dong et al.
4 citations
Crystal Growth & Design
Analytical Chemistry and Chromatography
3.03
article

Crystallization Resolution of a Racemic Compound (R,S)-Sulpiride Promoted by Chiral Ionic Liquids: Insight into the Effect on Selective Nucleation

Liang Shu, Jie Lü, Yinxin Yang, Longlong Dong, Xijian Liu, Ruhua Liu, Xiaoxuan Wang, Yue Xu, Yini Wang, Ruili Huang, Ran Wen, Yuxu Tao
article en
4 citations

Abstract

This study systematically investigates the influence of chiral ionic liquids (CILs) on the enantiomeric resolution efficiency of chiral drugs via crystallization. Four CILs―1-pentyl-3-methylimidazolium-R-mandelate ([Pmim][R-MA]), 1-pentyl-3-methylimidazolium-R-pyroglutamate ([Pmim][R-PgA]), 1-pentyl-3-methylimidazolium-S-mandelate ([Pmim][S-MA]), and 1-pentyl-3-methylimidazolium-S-pyroglutamate ([Pmim][S-PgA])―previously synthesized and characterized in prior research were employed in a methanol-based system to evaluate their effects on the nucleation kinetics and crystallization resolution of the model drug RS-sulpiride (RS-Sul). Nucleation probability analysis revealed that R-enantiomeric CILs (R-CILs) preferentially facilitated the nucleation of S-sulpiride (S-Sul), exhibiting intermolecular interactions with S-Sul that are significantly stronger than those with R-sulpiride (R-Sul). Furthermore, a CIL-based cosolvent mixture (CCM) with a mass fraction (ω) of 0.7 (CCM-0.7) was identified as a highly effective nucleation inhibitor, selectively suppressing the crystallization of enantiomers with identical chiral configurations while promoting the nucleation of their opposite enantiomers. In a methanol-based system containing 7 wt % R-CILs, variations in solvent composition and seeding concentrations significantly influenced the crystallization resolution efficiency of RS-Sul. The chiral recognition mechanism between CILs and Sul enantiomers was revealed by an independent gradient model based on Hirshfeld partition (IGMH) analysis as well as binding energy (BE) calculations, which further demonstrated that [Pmim][R-PgA] exhibited superior chiral recognition compared to [Pmim][R-MA], elucidating the molecular-level mechanism of CIL-mediated stereoselective nucleation. Additionally, cyclic stability assessments revealed that after six reuse cycles, the CILs retained a 93.8% recovery efficiency and structural integrity, highlighting their potential for practical applications in chiral resolution.

Crystal Growth & DesignVol. 25(9)
Pioneer (United States) (US), Shanghai University of Engineering Science (CN), Buchang Pharma (China) (CN)
National Natural Science Foundation of China
Openalex Percentile: Top 9%
Analytical Chemistry and Chromatography
3.03
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.